OA11838A - Gardos channel antagonists. - Google Patents

Gardos channel antagonists. Download PDF

Info

Publication number
OA11838A
OA11838A OA1200100220A OA1200100220A OA11838A OA 11838 A OA11838 A OA 11838A OA 1200100220 A OA1200100220 A OA 1200100220A OA 1200100220 A OA1200100220 A OA 1200100220A OA 11838 A OA11838 A OA 11838A
Authority
OA
OAPI
Prior art keywords
substituent
acetamide
ring
compound
para
Prior art date
Application number
OA1200100220A
Other languages
English (en)
Inventor
Grant Andrew Mcnaughton-Smith
Gregory Cooksey Rigdon
Jonathan Walter Stocker
Original Assignee
Icagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icagen Inc filed Critical Icagen Inc
Publication of OA11838A publication Critical patent/OA11838A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA1200100220A 1999-02-23 2000-02-10 Gardos channel antagonists. OA11838A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13551199P 1999-02-23 1999-02-23
US09/386,601 US6288122B1 (en) 1999-02-23 1999-08-31 Gardos channel antagonists

Publications (1)

Publication Number Publication Date
OA11838A true OA11838A (en) 2005-08-22

Family

ID=26833406

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100220A OA11838A (en) 1999-02-23 2000-02-10 Gardos channel antagonists.

Country Status (16)

Country Link
US (1) US6288122B1 (zh)
EP (1) EP1158971B1 (zh)
JP (2) JP4038337B2 (zh)
KR (1) KR100705726B1 (zh)
CN (1) CN1193748C (zh)
AP (1) AP1465A (zh)
AT (1) ATE370728T1 (zh)
AU (1) AU762039B2 (zh)
BR (1) BR0008416A (zh)
CA (1) CA2371857C (zh)
DE (1) DE60036093T2 (zh)
ES (1) ES2291191T3 (zh)
HK (1) HK1045262B (zh)
IL (2) IL145012A0 (zh)
OA (1) OA11838A (zh)
WO (1) WO2000050026A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
EP1465863B1 (en) * 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators
EP1487430A4 (en) * 2002-02-28 2007-08-22 Icagen Inc METHOD FOR THE TREATMENT OF DISEASES RELATED TO THE EYE REMINDER
WO2005003143A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Novel potassium channel modulators
EP1644332A1 (en) * 2003-07-03 2006-04-12 Poseidon Pharmaceuticals A/S Diarylmethyl derivatives as potassium channel modulators
CA2594505A1 (en) * 2005-02-01 2006-08-10 Icagen, Inc. Imines as ion channel modulators
AU2006331653B2 (en) * 2005-12-20 2010-03-11 Icagen, Inc. Treatment methods using triaryl methane compounds
US20100056637A1 (en) * 2005-12-20 2010-03-04 Icagen, Inc. Treatment methods using triaryl methane compounds
EP2322164A3 (en) 2007-08-24 2011-12-07 NeuroSearch A/S Carbonylamino derivatives useful for the treatment of inflammatory bowel disease
US20090076157A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched senicapoc
SG189745A1 (en) 2008-04-09 2013-05-31 Cerus Corp Improved quenching methods for red blood cell pathogen inactivation
AU2009311585A1 (en) 2008-11-10 2010-05-14 Boehringer Ingelheim International Gmbh Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
US10179115B2 (en) 2015-02-20 2019-01-15 The Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
EP3106155A1 (en) 2015-06-15 2016-12-21 Universite d'Aix Marseille Treatment and diagnosis of hereditary xerocytosis
AU2017350760B2 (en) * 2016-10-25 2022-03-31 Paracelsus Neuroscience I, LIc Use of senicapoc for treatment of neuropathic pain
WO2018162426A1 (en) 2017-03-06 2018-09-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Treatment and diagnosis of hereditary xerocytosis
CN112020353A (zh) * 2019-03-29 2020-12-01 深圳仁泰医药科技有限公司 2,2-双(4-氟苯基)-2-苯乙酰胺的晶型a及其制备方法和应用
US20230045322A1 (en) * 2019-07-29 2023-02-09 Paracelsus Neuroscience II, LLC Use of senicapoc for treatment of stroke
CN115943138A (zh) * 2020-07-14 2023-04-07 阿迪玛生物有限责任公司 包含gardos通道拮抗剂的组合物及其用途
EP4259130A1 (en) 2020-12-11 2023-10-18 Sanquin IP B.V. Treatment and prevention of anaemia of inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273992A (en) 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
AU732881C (en) 1994-09-16 2002-11-07 Children's Medical Center Corporation Triaryl and diaryl compounds, their analogues and uses thereof

Also Published As

Publication number Publication date
EP1158971A4 (en) 2003-04-16
CA2371857A1 (en) 2000-08-31
CN1193748C (zh) 2005-03-23
EP1158971A1 (en) 2001-12-05
AU2880700A (en) 2000-09-14
US6288122B1 (en) 2001-09-11
DE60036093T2 (de) 2008-05-15
IL145012A (en) 2006-12-10
HK1045262B (zh) 2005-07-29
ATE370728T1 (de) 2007-09-15
AU762039B2 (en) 2003-06-19
HK1045262A1 (en) 2002-11-22
JP2007262075A (ja) 2007-10-11
ES2291191T3 (es) 2008-03-01
KR20020002393A (ko) 2002-01-09
BR0008416A (pt) 2002-01-29
CA2371857C (en) 2008-07-29
CN1344158A (zh) 2002-04-10
EP1158971B1 (en) 2007-08-22
WO2000050026A1 (en) 2000-08-31
DE60036093D1 (de) 2007-10-04
JP4038337B2 (ja) 2008-01-23
KR100705726B1 (ko) 2007-04-11
AP2001002268A0 (en) 2001-09-30
IL145012A0 (en) 2002-06-30
AP1465A (en) 2005-09-22
JP2002537331A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
OA11838A (en) Gardos channel antagonists.
US6512136B1 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
US20210094900A1 (en) Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds
KR20150131240A (ko) 바이사이클릭 진통 화합물
PL154186B1 (en) Method for manufacturing arylic derivatives of the hydroxamic acid
JPH04270261A (ja) イソプレノイドホスホリパーゼ▲ａ２▼阻害剤およびそれを包含する製剤
JPS61218570A (ja) 新規複素環アミド化合物、およびそれらを含有する医薬組成物
US4797391A (en) ((5,6-dichloro-3-oxo-9,9a-disubstituted-2,3,9,9a-tetrahydrofluoren-7-yl)oxy)alkanoic acids and alkanimidamides
CS267551B1 (en) Pharmaceutical agents for asthma treatment and method of effective substance production
AU2006320567A1 (en) Inhibitors of kynurenine aminotransferase and uses therefor
US4562206A (en) Orally effective inotropic compounds
US3856951A (en) Substituted benzoic acid hypoliphemic agents
ZA200106847B (en) Gardos channel antagonists.
US4418074A (en) 2,6 Di(t-butyl)-4-(2'-pyrrol)-phenol and anti-inflammatory use thereof
US20060100289A1 (en) Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
JPS6330283B2 (zh)
US3457354A (en) Treatment of hypertension with 2-hydroxy (or amino) - 4,5 - dihydroxyphenethylamine derivatives
JPH08325154A (ja) 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼａ２阻害剤
US4567192A (en) Acylaminophenol derivatives
US4146728A (en) Esters of 2-[4-(4-chlorobenzoyl)-phenoxy-2-methyl-propionic acid with bis-(hydroxyalkylthio)-alkanes
US4124706A (en) Esters of bis-(hydroxyalkylthio)-alkanes
US3740395A (en) Ethyl 10 - (beta-morpholylpropionyl)-phenthiazine-2-carbamate hydrochloride
US3673197A (en) Exo-dibicycloalkane carboxamides
US20240350448A1 (en) Dichloroacetic acid conjugating diphenyl ethane compound, and preparation method and application thereof
JPH0374673B2 (zh)